FDA updates claim on calcium, osteoporosis

WASHINGTON, Jan. 5 (UPI) -- The U.S. Food and Drug Administration proposed an amended health claim on value of foods rich in calcium and vitamin D in reducing osteoporosis risk.

The proposal would allow new claims on foods and dietary supplements containing calcium and Vitamin D to show their potential to reduce the risk of osteoporosis, the FDA said in a news release. It would allow manufacturers to include new information on their food and supplement labeling.

"This is important information," said Robert E. Brackett, director of FDA's Center for Food Safety and Nutrition. "All persons lose bone with age, and the loss can influence an individual's risk of developing osteoporosis. Maintenance of an adequate intake of calcium and vitamin D in all stages of life can help lower one's risk."

The claim will provide a clearer way to communicate the benefits of the nutrients in bone health, said Ann Marie Krautheim, registered dietitian and senior vice president of nutrition and health promotion of the National Dairy Council.

The proposed model health claim language, subject to final approval, describes the relationship physical activity, healthy diet, calcium and vitamin D have in possibly reducing the risk of osteoporosis.